Trial of Underwater Versus Gas-Insufflation Colorectal Endoscopic Submucosal DisseEtion
TIDE
Underwater Versus Conventional Endoscopic Submucosal Dissection For Colorectal Neoplasia: A Multicenter, Randomised Controlled Trial
1 other identifier
interventional
295
1 country
1
Brief Summary
Colorectal endoscopic submucosal dissection (ESD) enables en bloc resection of large superficial colorectal neoplasia but remains technically demanding and may be limited by suboptimal visualization, intraprocedural bleeding, smoke accumulation, and prolonged procedural time. Underwater ESD (UESD), performed under saline immersion rather than gas insufflation, has been proposed as a strategy to improve the operative field and facilitate submucosal dissection. This prospective, multicenter, open-label, randomized controlled trial was designed to compare UESD with conventional gas-assisted ESD (GESD) for colorectal neoplasia referred for ESD across Italian tertiary centers. The primary objective was to assess non-inferiority of UESD versus GESD in terms of en bloc resection. Secondary objectives included comparison of histological resection quality, procedural efficiency, intraprocedural events, procedural field visualization, and post-procedural adverse events.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedFirst Submitted
Initial submission to the registry
March 18, 2026
CompletedFirst Posted
Study publicly available on registry
March 24, 2026
CompletedMarch 31, 2026
March 1, 2026
1 year
March 18, 2026
March 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
En bloc resection rate
Proportion of lesions resected in a single specimen.
During the index procedure
Secondary Outcomes (12)
R0 resection rate
During index procedure and histopathological assessment within 30 days
Procedural time
During the index procedure
Dissection speed
During the index procedure
Intraprocedural bleeding rate
During the index procedure
Use of hemostatic forceps
During the index procedure
- +7 more secondary outcomes
Study Arms (2)
Underwater Endoscopic Submucosal Dissection (UESD)
EXPERIMENTALUnderwater endoscopic submucosal dissection was performed after placement of the lesion on the anti-gravity side whenever feasible, discontinuation of luminal insufflation, and filling of the target colonic segment with saline solution to obtain stable immersion of the operative field. After immersion, mucosal incision and submucosal dissection were completed according to standard ESD principles, using either a conventional stepwise or tunnel-based strategy according to lesion characteristics and operator preference. Only saline solution was standardized across centers; device selection, generator settings, and ancillary maneuvers were otherwise left to operator discretion. Hemostasis, when required, was achieved using hemostatic forceps.
Conventional Gas-Assisted Endoscopic Submucosal Dissection (GESD)
ACTIVE COMPARATORConventional colorectal ESD was performed under gas insufflation according to standard practice at each participating center. Mucosal incision and submucosal dissection were carried out according to standard ESD technique. Device selection, generator settings, and technical dissection strategy were left to operator discretion. Hemostasis, when required, was achieved using hemostatic forceps.
Interventions
Underwater ESD (UESD) performed under saline immersion with luminal insufflation turned off.
Conventional colorectal ESD was performed under gas insufflation according to standard practice at each participating center. Mucosal incision and submucosal dissection were carried out according to standard ESD technique. Device selection, generator settings, and technical dissection strategy were left to operator discretion. Hemostasis, when required, was achieved using hemostatic forceps.
Eligibility Criteria
You may qualify if:
- Adults aged 19 years or older
- Colorectal neoplastic lesion referred for endoscopic submucosal dissection
- Lesion considered amenable to en bloc endoscopic resection by ESD according to expert pre-procedural endoscopic assessment
- Written informed consent provided
You may not qualify if:
- Known or suspected deep invasive neoplasia
- Inflammatory bowel disease
- Uninterrupted antithrombotic therapy
- Known coagulopathy
- Any clinical or lesion-related condition considered unsuitable for colorectal ESD by the treating endoscopist
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Roma La Sapienzalead
- Campus Bio-Medico Universitycollaborator
Study Sites (1)
Campus Bio Medico Hospital
Rome, RM, 00100, Italy
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
March 18, 2026
First Posted
March 24, 2026
Study Start
December 1, 2024
Primary Completion
December 1, 2025
Study Completion
March 1, 2026
Last Updated
March 31, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- after the publication, for 5 years at least
Anonymsed data upon written and motivated requests